Pandina, Gahan http://orcid.org/0000-0003-0050-3575
Ness, Seth
Trudeau, Jeremiah
Stringer, Sonja
Knoble, Naomi
Lenderking, William R.
Bangerter, Abigail
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 24 April 2020
Accepted: 30 December 2020
First Online: 20 January 2021
Ethics approval and consent to participate
: Institutional Review Board (IRB) approval of the study protocol and electronic informed consent was obtained prior to completion of any study procedures. The study was approved by Quorum IRB. Informed consent was obtained from all participants (caregivers of individuals with ASD) prior to completion of any study procedures. All participants were over 18 years of age.
: Not applicable.
: GP, AB, SN and JT are employees of Janssen Research & Development, LLC, and may hold company stock/stock options. SS and WRL are employees of Evidera, a business unit of Pharmaceutical Product Development, LLC, a paid consultant for this study. NK was an employee of Evidera at the time the work was conducted and the first draft of the manuscript was drafted, but is now with the FDA Division of Clinical Outcomes Assessment (DCOA).